ANI Pharmaceuticals
ANIP
#5269
Rank
HK$12.97 B
Marketcap
HK$564.78
Share price
-1.59%
Change (1 day)
-20.94%
Change (1 year)

EPS for ANI Pharmaceuticals (ANIP)

EPS in 2026 (TTM): HK$37.73

According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$37.89. In 2025 the company made an earnings per share (EPS) of HK$27.45 an increase over its 2024 EPS that were of -HK$8.79.

EPS history for ANI Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$37.7337.41%
2025HK$27.45-412.5%
2024-HK$8.79
2022-HK$23.85-6.46%
2021-HK$25.4972.87%
2020-HK$14.75-476%
2019HK$3.92-62.12%
2018HK$10.35
2015HK$10.51-47.66%
2014HK$20.08-142.11%
2013-HK$47.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$52.24 37.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96-84.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
HK$56.95 50.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
HK$119.62 215.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
-HK$19.77-152.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.12-190.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.94-86.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
HK$14.71-61.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
-HK$198.30-623.40%๐Ÿ‡บ๐Ÿ‡ธ USA